E. Kabova

The principles underlying the use of powder diffraction data in solving pharmaceutical crystal structures.

Mark J. Spillman, K. Shankland, N. Shankland, 2013, Acta crystallographica. Section C, Crystal structure communications.

Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy

K. Shankland, F. Greco, A. Attinà, 2017, Scientific Reports.

Improved performance of crystal structure solution from powder diffraction data through parameter tuning of a simulated annealing algorithm

M. López-Ibáñez, J. Cole, K. Shankland, 2017 .

Utilizing organic and organometallic structural data in powder diffraction

J. Cole, K. Shankland, E. Kabova, 2014, Powder Diffraction.

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation

K. Shankland, F. Greco, I. Hamley, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Property enhancement of healable supramolecular polyurethanes

K. Shankland, R. Wildman, D. Irvine, 2019, European Polymer Journal.

Structure and spectroscopy of methionyl-methionine for aquaculture

K. Shankland, S. Parker, P. Albers, 2021, Scientific reports.

Improved crystal structure solution from powder diffraction data by the use of conformational information

J. Cole, K. Shankland, O. Korb, 2017, Acta Crystallographica Section A Foundations and Advances.

Salt and ionic cocrystalline forms of amides : protonation of carbamazepine in aqueous media

Mark J. Spillman, K. Shankland, D. Hooper, 2015 .

Pushing the Limits of Molecular Crystal Structure Determination From Powder Diffraction Data in High-Throughput Chemical Environments.

K. Shankland, C. Blundell, E. Kabova, 2018, Journal of pharmaceutical sciences.

Enhanced structure determination from powder diffraction data via algorithm optimisation and the use of conformational information

Elena A. Kabova, E. Kabova, 2016 .